4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000032
Options or other derivatives
- Chief Executive Officer acquired 217,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-08 | Grant or award : show line 1 in the form Stock options (right to buy) | +170,000 | 170,000 | D |
| 2022-04-08 | Grant or award : show line 2 in the form Restricted stock units | +47,800 | 47,800 | D |
Loading xslF345X03/wf-form4_164979367185851.xml…